Topcare
Pricing Report NDC 36800-062-00

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Topcare Clotrimazole 3 (NDC 36800-062-00) is $0.31646 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 19, 2021.

As a provided by Topco Associates Llc, this medication is distributed in a 1 TUBE, WITH APPLICATOR in 1 CARTON / 21 g in 1 TUBE, WITH APPLICATOR configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.31646
Per GM

Effective Date
May 19, 2021
Billable Units
21 GM
Estimated Package Price
$6.65
Data Status
As of May 26, 2021
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 TUBE, WITH APPLICATOR in 1 CARTON / 21 g in 1 TUBE, WITH APPLICATOR
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Mar 2020, the NADAC wholesale price for (NDC ) has moved within a range of $0.30024 to $0.31892 per GM. Over this 1 year and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.3002 - $0.3189
Market Volatility
6.22% Variance
Latest Trend
0.97%
Date Unit Price Unit Source Method Rate
May 19, 2021 $0.31646 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 21, 2021 $0.31342 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 17, 2021 $0.31868 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 17, 2021 $0.31283 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 20, 2021 $0.31882 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 23, 2020 $0.31301 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 18, 2020 $0.30786 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 21, 2020 $0.31093 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 23, 2020 $0.31719 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 19, 2020 $0.31565 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 22, 2020 $0.31512 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 17, 2020 $0.31417 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 20, 2020 $0.31844 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 22, 2020 $0.30024 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 25, 2020 $0.31892 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026